You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ripretinib

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • GIST
  • (no location specified)
Jul 14, 2023

GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)

Recruiting
  • GIST - Gastrointestinal Stromal Tumor
  • Jacksonville, Florida
  • +2 more
Mar 7, 2022

Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)

Withdrawn
  • Gastrointestinal Stromal Tumors
  • (no location specified)
Dec 15, 2021

GIST - Gastrointestinal Stromal Tumor Trial (ripretinib)

Approved for marketing
  • GIST - Gastrointestinal Stromal Tumor
  • ripretinib
  • (no location specified)
May 27, 2020

Gastrointestinal Stromal Tumor(GIST) Trial in China (Ripretinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumor(GIST)
  • Beijing, Beijing, China
  • +17 more
Dec 17, 2020